High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer

High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer

Bibliographic Details
Main Authors:	Mauland, K K, Trovik, J, Wik, E, Raeder, M B, Njølstad, T S, Stefansson, I M, Øyan, A M, Kalland, K H, Bjørge, T, Akslen, L A, Salvesen, H B
Format:	Online
Language:	English
Published:	Nature Publishing Group 2011
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065282/

Similar Items

Lipocalin 2 expression is associated with aggressive features of endometrial cancer
by: Mannelqvist, Monica, et al.
Published: (2012)

KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer
by: Birkeland, E, et al.
Published: (2012)

Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer
by: Stefansson, Ingunn M., et al.
Published: (2015)

High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors
by: Engerud, H, et al.
Published: (2014)

Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome
by: Krakstad, C, et al.
Published: (2012)

Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses
by: Bredholt, Geir, et al.
Published: (2015)

ATAD2 overexpression links to enrichment of B-MYB-translational signatures and development of aggressive endometrial carcinoma
by: Krakstad, Camilla, et al.
Published: (2015)

Switch in FOXA1 Status Associates with Endometrial Cancer Progression
by: Tangen, Ingvild Løberg, et al.
Published: (2014)

Integrated Genomic Analysis of the 8q24 Amplification in Endometrial Cancers Identifies ATAD2 as Essential to MYC-Dependent Cancers
by: Raeder, Maria B., et al.
Published: (2013)

An 18-Gene Signature for Vascular Invasion Is Associated with Aggressive Features and Reduced Survival in Breast Cancer
by: Mannelqvist, Monica, et al.
Published: (2014)

Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene
by: Hoivik, Erling A., et al.
Published: (2014)

Stathmin Protein Level, a Potential Predictive Marker for Taxane Treatment Response in Endometrial Cancer
by: Werner, Henrica M. J., et al.
Published: (2014)

Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomas
by: Haldorsen, I S, et al.
Published: (2014)

Preoperative Tumor Size at MRI Predicts Deep Myometrial Invasion, Lymph Node Metastases, and Patient Outcome in Endometrial Carcinomas
by: Ytre-Hauge, Sigmund, et al.
Published: (2015)

Independent prognostic importance of microvessel density in endometrial carcinoma.
by: Salvesen, H. B., et al.
Published: (1998)

High-Throughput Mutation Profiling of Primary and Metastatic Endometrial Cancers Identifies KRAS, FGFR2 and PIK3CA to Be Frequently Mutated
by: Krakstad, Camilla, et al.
Published: (2012)

Endometrial progesterone resistance and PCOS
by: Li, Xin, et al.
Published: (2014)

Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients
by: Berg, Anna, et al.
Published: (2014)

PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer
by: Siv Mjos, et al.
Published: (2017-08-01)

Progesterone Inhibits Epithelial-to-Mesenchymal Transition in Endometrial Cancer
by: van der Horst, Paul H., et al.
Published: (2012)

The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis
by: Gibson, William J., et al.
Published: (2016)

Distribution of estrogen and progesterone receptors isoforms in endometrial cancer
by: Kreizman-Shefer, Hila, et al.
Published: (2014)

Aggressive periodontitis: A clinico-hematological appraisal
by: Kundu, Debabrata, et al.
Published: (2014)

Inverse Relationship between Progesterone Receptor and Myc in Endometrial Cancer
by: Kavlashvili, Tamar, et al.
Published: (2016)

Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometrial cancer
by: Yang, Shujie, et al.
Published: (2014)

What Is the Best Preoperative Imaging for Endometrial Cancer?
by: Haldorsen, Ingfrid S., et al.
Published: (2016)

Progesterone receptor isoforms A and B: new insights into the mechanism of progesterone resistance for the treatment of endometrial carcinoma
by: Shao, Ruijin
Published: (2013)

Endometrial Stromal Sarcomas: A clinico-pathological analysis of 27 patients
by: Kim, Dae-Young, et al.
Published: (2013)

DNA ploidy in curettage specimens identifies high-risk patients and lymph node metastasis in endometrial cancer
by: Njølstad, T S, et al.
Published: (2015)

Delineating the prime mover action of progesterone for endometrial receptivity in primates
by: Ghosh, D., et al.
Published: (2014)

Clinico-social and pathopsychological risk factors of nosocomial aggression in various categories of patients
by: V.G. Bulygina,, et al.
Published: (2014-08-01)

miR-888: A Novel Cancer-Testis Antigen that Targets the Progesterone Receptor in Endometrial Cancer12
by: Hovey, Adriann M., et al.
Published: (2015)

Gene expression in tumor cells and stroma in dsRed 4T1 tumors in eGFP-expressing mice with and without enhanced oxygenation
by: Moen, Ingrid, et al.
Published: (2012)

Lumbee Native American ancestry and the incidence of aggressive histologic subtypes of endometrial cancer
by: Zhang, Chelsea, et al.
Published: (2015)

BMI and Lifetime Changes in BMI and Cancer Mortality Risk
by: Taghizadeh, Niloofar, et al.
Published: (2015)

Differences in progesterone concentrations and mRNA expressions of progesterone receptors in bovine endometrial tissue between the uterine horns ipsilateral and contralateral to the corpus luteum
by: TAKAHASHI, Hiroto, et al.
Published: (2016)

Endometrial gene expression reveals compromised progesterone signaling in women refractory to embryo implantation
by: Tapia-Pizarro, Alejandro, et al.
Published: (2014)

p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans
by: Wild, Peter J, et al.
Published: (2012)

Stromal Clues in Endometrial Carcinoma: Loss of Expression of β-Catenin, Epithelial-Mesenchymal Transition Regulators, and Estrogen-Progesterone Receptor
by: Senol, Serkan, et al.
Published: (2016)

The Lymphocyte-Monocyte Ratio Predicts Patient Survival and Aggressiveness of Endometrial Cancer
by: Eo, Wan Kyu, et al.
Published: (2016)